Latest Healthcare Research Reports

Tag: Cell Therapy Processing Market Size

  • Global cell processing technologies market to reach $9.24B by 2030 at 13.5% CAGR

    Global cell processing technologies market to reach $9.24B by 2030 at 13.5% CAGR

    The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

    What Is The Projected Increase In Market Value Of The Cell Processing Technologies Market During 2026–2030?

    The cell processing technologies market size has seen swift expansion in recent years. It is forecast to grow from $4.89 billion in 2025 to $5.56 billion in 2026, registering a compound annual growth rate (CAGR) of 13.7%. Historically, this growth can be ascribed to the broadening of cell-based research activities, the increased utilization of cell culture techniques, advancements in regenerative medicine research, the accessibility of sophisticated laboratory equipment, and a rise in academic and clinical research funding.

    The cell processing technologies market size is projected to experience substantial growth in the coming years. It is anticipated to reach $9.24 billion by 2030, driven by a compound annual growth rate (CAGR) of 13.5%. This growth during the forecast period is attributable to factors such as the increasing commercialization of cell therapies, a growing demand for scalable cell manufacturing, the expansion of personalized medicine applications, rising investments in bioprocess automation, and an increasing regulatory focus on cell processing standards. Significant trends in the forecast period encompass the increasing adoption of automated cell processing systems, a rising demand for closed-system cell handling technologies, the growing integration of digital process monitoring, the expansion of single-use consumables, and an enhanced focus on cell viability and quality control.

    Access Your Free Sample Report For In-Depth Market Analysis:

    https://www.thebusinessresearchcompany.com/report/cell-processing-technologies-global-market-report

    Which Primary Drivers Are Impacting The Cell Processing Technologies Market Growth?

    The expansion of personalized medicine is anticipated to fuel the growth of the cell processing technologies market moving forward. This medical approach customizes treatments for individual patients, considering their genetic, environmental, and lifestyle factors to optimize care and outcomes. The demand for personalized medicine is escalating due to progress in genomic technologies, which facilitate precise identification of genetic variations and the creation of tailored treatments. Cell processing technologies are crucial for personalized medicine as they enable precise manipulation and preparation of patient-specific cells, vital for bespoke therapies. They enhance treatment effectiveness by ensuring high-quality, viable cells, thereby advancing targeted and efficient medical interventions. For instance, in February 2024, the Personalized Medicine Coalition (PMC), a US-based nonprofit, reported that the U.S. Food and Drug Administration (FDA) approved 26 new personalized medicines in 2023, an increase from 12 approved in 2022. Consequently, the increasing adoption of personalized therapies is propelling the growth of the cell processing technologies market.

    How Are Segments Identified Within The Cell Processing Technologies Market Segment Framework?

    The cell processing technologies market covered in this report is segmented –

    1) By Product Type: Equipment, Consumables, Software

    2) By Application: Oncology, Cardiovascular Disease, Bone Repair, Neurological Disorders, Skeletal Muscle Repair, Immune Diseases, Other Applications

    3) By End-User: Pharmaceutical and Biotechnology Companies, Academic Research Institutes, Other End-Users

    Subsegments:

    1) By Equipment: Bioreactors, Centrifuges, Cell Counters, Incubators, Cryopreservation Systems, Cell Washers, Cell Sorters, Microscopes

    2) By Consumables: Cell Culture Media, Reagents, Pipettes and Tips, Flasks and Plates, Cryovials, Filters, Disposable Bags, Tubes and Containers

    3) By Software: Process Monitoring Software, Data Management Software, Automation Control Software, Quality Control Software, Imaging and Analysis Software, Inventory Management Software

    Which Trends Are Shaping Growth In The Cell Processing Technologies Market?

    Major companies within the cell processing technologies market are prioritizing the development of technologically advanced solutions, such as automated cell therapy manufacturing platforms, to enhance scalability, improve process efficiency, elevate cell quality, and reduce production costs. An automated cell therapy manufacturing platform signifies a fully integrated system that utilizes advanced robotics, sensors, and software to perform the entire process of producing cell-based therapies with minimal manual intervention. For instance, in March 2025, Limula SA, a Switzerland-based life sciences company, launched LimONE, a completely automated cell therapy manufacturing platform designed to transform the production of advanced therapies like CAR-T and gene-edited stem cells. It streamlines complex manufacturing processes by integrating a bioreactor and centrifuge into a single, closed device that employs one consumable across all development stages. LimONE empowers hospitals, biotech firms, and manufacturers to accelerate the transition from research to clinical trials and commercial production, making life-saving, personalized cell and gene therapies more accessible to patients.

    Who Are The Companies Competing Within The Cell Processing Technologies Market?

    Major companies operating in the cell processing technologies market are Thermo Fisher Scientific Inc., Danaher Corporation, Cryo-Cell International Inc., Merck KGaA, Becton Dickinson and Company, Lonza Group AG, Terumo Corporation, WuXi AppTec Co. Ltd., Charles River Laboratories International Inc., Bio-Rad Laboratories Inc., PHC Holdings Corporation, Bio-Techne Corporation, StemCell Technologies Inc., Shibuya Corporation, Repligen Corporation, Beckman Coulter Inc., ThermoGenesis Holdings Inc., Ori Biotech Ltd., Biospherix Ltd., Miltenyi Biotec B.V. & Co. KG, Sartorius Stedim Biotech, Cytiva

    Get The Full Cell Processing Technologies Market Report:

    https://www.thebusinessresearchcompany.com/report/cell-processing-technologies-global-market-report

    Which Region Leads The Cell Processing Technologies Market In Terms Of Market Share?

    North America was the largest region in the cell processing technologies market in 2025. The regions covered in the cell processing technologies market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Request A Customized Cell Processing Technologies Market Report For Competitive Insights:

    https://www.thebusinessresearchcompany.com/report/cell-processing-technologies-global-market-report

    Browse Through More Reports Similar to the Global Cell Processing Technologies Market 2026, By The Business Research Company

    Vacuum Insulation Panel Market Report 2026

    https://www.thebusinessresearchcompany.com/report/vacuum-insulation-panel-global-market-report

    Sandwich Panels Market Report 2026

    https://www.thebusinessresearchcompany.com/report/sandwich-panels-global-market-report

    Structural Insulated Panels Market 2026

    https://www.thebusinessresearchcompany.com/report/structural-insulated-panels-market

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Asia +44 7882 955267 & +91 8897263534

    Europe +44 7882 955267

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Global Cell Processing Instruments Market Expected To Reach $10.1 Billion By 2030 At 7.7% CAGR

    Global Cell Processing Instruments Market Expected To Reach $10.1 Billion By 2030 At 7.7% CAGR

    The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

    What Expansion In Market Value Is Forecasted For The Cell Processing Instruments Market Between 2026 And 2030?

    The cell processing instruments market size has demonstrated significant expansion in recent years. This market is anticipated to increase from $6.95 billion in 2025 to $7.51 billion in 2026, progressing at a compound annual growth rate (CAGR) of 8.1%. Historically, this growth can be ascribed to several factors, including the previous lack of automation in cell processing, a dependence on manual cell counting and separation techniques, an escalation in academic and research activities, a heightened requirement for precise cell analysis, and the emergence of flow cytometry technologies.

    The cell processing instruments market is anticipated to experience substantial expansion in the coming years, with projections indicating it will reach $10.1 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 7.7%. This growth is primarily driven by the development of integrated cell processing platforms, increasing investment in cell therapy and regenerative medicine, the adoption of digital and automated imaging systems, a rise in contract research and manufacturing activities, and advancements in live cell analysis and high-content screening. Furthermore, significant trends for this period include a heightened demand for automated cell processing systems, the growing adoption of flow cytometry and high-content imaging, the expansion of cell therapy and regenerative medicine applications, an emphasis on standardization and regulatory compliance, and the integration of multi-functional cell analysis platforms.

    Access Your Free Sample Report For In-Depth Market Analysis:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=27242&type=smp

    Which Strong Drivers Are Impacting The Cell Processing Instruments Market Growth?

    The increasing investment in biopharmaceutical research is expected to propel the growth of the cell processing instruments market going forward. Biopharmaceutical research refers to the scientific study and development of therapeutic products derived from biological sources or designed to mimic biological molecules for diagnosing, preventing, or treating diseases. The growing demand for innovative therapies to address rising chronic diseases and unmet medical needs is driving this increasing investment, prompting greater research and development efforts for targeted, effective treatments. Cell processing instruments support biopharmaceutical research by enabling efficient, standardized, and scalable cell handling, which accelerates the development and production of advanced cell-based therapies. For instance, in January 2025, according to the BioIndustry Association (BIA), a UK-based trade association, the UK biotech sector experienced substantial growth in 2024, securing £3.5 billion (approximately $ 4.4 billion) in investment, an impressive 94% increase from the previous year. Therefore, the increasing investment in biopharmaceutical research is driving the growth of the cell processing instruments market.

    How Is The Cell Processing Instruments Market Categorized Across Its Segment Groups?

    The cell processing instruments market covered in this report is segmented –

    1) By Type: Cell Counters, Cell Imaging Systems, Flow Cytometers, Cell Separator Systems, Automated Cell Processing Systems, Other Instruments

    2) By Application: Cell Isolation Or Separation, Cell Imaging And Counting, Cell Viability And Proliferation, Other Applications

    3) By End-Use: Pharmaceutical And Biotechnology Companies, Contract Research Organizations (CROs) And Contract Manufacturing Organizations (CMOs), Academic And Research Institutes, Other End-Uses

    Subsegments:

    1) By Cell Counters: Manual Cell Counters, Automated Cell Counters, Digital Cell Counters

    2) By Cell Imaging Systems: Brightfield Imaging Systems, Fluorescence Imaging Systems, High-Content Imaging Systems, Live Cell Imaging Systems

    3) By Flow Cytometers: Analog Flow Cytometers, Digital Flow Cytometers, Benchtop Flow Cytometers, Clinical Flow Cytometers

    4) By Cell Separator Systems: Magnetic-Activated Cell Sorting (MACS) Systems, Fluorescence-Activated Cell Sorting (FACS) Systems, Centrifugal Elutriation Systems

    5) By Automated Cell Processing Systems: Cell Expansion Systems, Cell Washing And Concentration Systems, Cell Harvesting Systems, Integrated Cell Processing Platforms

    6) By Other Instruments: Cell Disruption Systems, Cell Viability Analyzers, Centrifuges For Cell Processing, Cell Freezing And Thawing Systems

    Which Trends Are Contributing To Changes In The Cell Processing Instruments Market?

    Companies within the cell processing instruments market are prioritizing the creation of advanced methods, including multi-channel asynchronous processing, to elevate workflow effectiveness and flexibility in cell therapy development. Multi-channel asynchronous processing provides a system with the capacity to run multiple separate workflows simultaneously on distinct channels, allowing different operations to proceed in parallel without needing to wait for one another. As an illustration, in June 2023, Singleron Biotechnologies GmbH, a German biotechnology company, unveiled two new instruments, Python Junior and Matrix NEO, designed to refine and standardize the single-cell analysis workflow. Python Junior facilitates the dissociation of solid tissues into premium single-cell suspensions using dual independent channels through a blend of mechanical and enzymatic processing, whereas Matrix NEO allows for high-throughput, fully automated single-cell library preparation, covering chip priming, cell partitioning, lysis, and nucleic acid capture across four channels, thereby accommodating various applications and throughput requirements in both research and clinical settings.

    Which Firms Are Influencing Competition In The Cell Processing Instruments Market?

    Major companies operating in the cell processing instruments market are Thermo Fisher Scientific Inc., Danaher Corporation, Merck KGaA, Becton Dickinson and Company, Avantor Inc., Agilent Technologies Inc., Sartorius AG, Revvity Inc., Bio-Rad Laboratories Inc., Eppendorf SE, Tecan Group Ltd., Bio-Techne Corporation, STEMCELL Technologies Inc., Miltenyi Biotec B.V. & Co. KG, Takara Bio Inc., 10x Genomics Inc., Promega Corporation, Esco Lifesciences Group Ltd., NanoCellect Biomedical Inc., InGeneron Inc.

    Get The Full Cell Processing Instruments Market Report:

    https://www.thebusinessresearchcompany.com/report/cell-processing-instruments-global-market-report

    Which Geographic Region Dominates The Cell Processing Instruments Market?

    North America was the largest region in the cell processing instruments market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cell processing instruments market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Request A Customized Cell Processing Instruments Market Report For Competitive Insights:

    https://www.thebusinessresearchcompany.com/customise?id=27242&type=smp

    Browse Through More Reports Similar to the Global Cell Processing Instruments Market 2026, By The Business Research Company

    Cell Free Dna Isolation And Extraction Market Report 2026

    https://www.thebusinessresearchcompany.com/report/cell-free-dna-isolation-and-extraction-global-market-report

    Dna Diagnostics Market Report 2026

    https://www.thebusinessresearchcompany.com/report/dna-diagnostics-global-market-report

    Dna Testing Market Report 2026

    https://www.thebusinessresearchcompany.com/report/dna-testing-global-market-report

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Asia +44 7882 955267 & +91 8897263534

    Europe +44 7882 955267

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Global Cell Processing Instruments Market Expected To Reach $10.1 Billion By 2030 At 7.7% CAGR

    Global Cell Processing Instruments Market Expected To Reach $10.1 Billion By 2030 At 7.7% CAGR

    The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

    What Expansion In Market Value Is Forecasted For The Cell Processing Instruments Market Between 2026 And 2030?

    The cell processing instruments market size has demonstrated significant expansion in recent years. This market is anticipated to increase from $6.95 billion in 2025 to $7.51 billion in 2026, progressing at a compound annual growth rate (CAGR) of 8.1%. Historically, this growth can be ascribed to several factors, including the previous lack of automation in cell processing, a dependence on manual cell counting and separation techniques, an escalation in academic and research activities, a heightened requirement for precise cell analysis, and the emergence of flow cytometry technologies.

    The cell processing instruments market is anticipated to experience substantial expansion in the coming years, with projections indicating it will reach $10.1 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 7.7%. This growth is primarily driven by the development of integrated cell processing platforms, increasing investment in cell therapy and regenerative medicine, the adoption of digital and automated imaging systems, a rise in contract research and manufacturing activities, and advancements in live cell analysis and high-content screening. Furthermore, significant trends for this period include a heightened demand for automated cell processing systems, the growing adoption of flow cytometry and high-content imaging, the expansion of cell therapy and regenerative medicine applications, an emphasis on standardization and regulatory compliance, and the integration of multi-functional cell analysis platforms.

    Access Your Free Sample Report For In-Depth Market Analysis:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=27242&type=smp

    Which Strong Drivers Are Impacting The Cell Processing Instruments Market Growth?

    The increasing investment in biopharmaceutical research is expected to propel the growth of the cell processing instruments market going forward. Biopharmaceutical research refers to the scientific study and development of therapeutic products derived from biological sources or designed to mimic biological molecules for diagnosing, preventing, or treating diseases. The growing demand for innovative therapies to address rising chronic diseases and unmet medical needs is driving this increasing investment, prompting greater research and development efforts for targeted, effective treatments. Cell processing instruments support biopharmaceutical research by enabling efficient, standardized, and scalable cell handling, which accelerates the development and production of advanced cell-based therapies. For instance, in January 2025, according to the BioIndustry Association (BIA), a UK-based trade association, the UK biotech sector experienced substantial growth in 2024, securing £3.5 billion (approximately $ 4.4 billion) in investment, an impressive 94% increase from the previous year. Therefore, the increasing investment in biopharmaceutical research is driving the growth of the cell processing instruments market.

    How Is The Cell Processing Instruments Market Categorized Across Its Segment Groups?

    The cell processing instruments market covered in this report is segmented –

    1) By Type: Cell Counters, Cell Imaging Systems, Flow Cytometers, Cell Separator Systems, Automated Cell Processing Systems, Other Instruments

    2) By Application: Cell Isolation Or Separation, Cell Imaging And Counting, Cell Viability And Proliferation, Other Applications

    3) By End-Use: Pharmaceutical And Biotechnology Companies, Contract Research Organizations (CROs) And Contract Manufacturing Organizations (CMOs), Academic And Research Institutes, Other End-Uses

    Subsegments:

    1) By Cell Counters: Manual Cell Counters, Automated Cell Counters, Digital Cell Counters

    2) By Cell Imaging Systems: Brightfield Imaging Systems, Fluorescence Imaging Systems, High-Content Imaging Systems, Live Cell Imaging Systems

    3) By Flow Cytometers: Analog Flow Cytometers, Digital Flow Cytometers, Benchtop Flow Cytometers, Clinical Flow Cytometers

    4) By Cell Separator Systems: Magnetic-Activated Cell Sorting (MACS) Systems, Fluorescence-Activated Cell Sorting (FACS) Systems, Centrifugal Elutriation Systems

    5) By Automated Cell Processing Systems: Cell Expansion Systems, Cell Washing And Concentration Systems, Cell Harvesting Systems, Integrated Cell Processing Platforms

    6) By Other Instruments: Cell Disruption Systems, Cell Viability Analyzers, Centrifuges For Cell Processing, Cell Freezing And Thawing Systems

    Which Trends Are Contributing To Changes In The Cell Processing Instruments Market?

    Companies within the cell processing instruments market are prioritizing the creation of advanced methods, including multi-channel asynchronous processing, to elevate workflow effectiveness and flexibility in cell therapy development. Multi-channel asynchronous processing provides a system with the capacity to run multiple separate workflows simultaneously on distinct channels, allowing different operations to proceed in parallel without needing to wait for one another. As an illustration, in June 2023, Singleron Biotechnologies GmbH, a German biotechnology company, unveiled two new instruments, Python Junior and Matrix NEO, designed to refine and standardize the single-cell analysis workflow. Python Junior facilitates the dissociation of solid tissues into premium single-cell suspensions using dual independent channels through a blend of mechanical and enzymatic processing, whereas Matrix NEO allows for high-throughput, fully automated single-cell library preparation, covering chip priming, cell partitioning, lysis, and nucleic acid capture across four channels, thereby accommodating various applications and throughput requirements in both research and clinical settings.

    Which Firms Are Influencing Competition In The Cell Processing Instruments Market?

    Major companies operating in the cell processing instruments market are Thermo Fisher Scientific Inc., Danaher Corporation, Merck KGaA, Becton Dickinson and Company, Avantor Inc., Agilent Technologies Inc., Sartorius AG, Revvity Inc., Bio-Rad Laboratories Inc., Eppendorf SE, Tecan Group Ltd., Bio-Techne Corporation, STEMCELL Technologies Inc., Miltenyi Biotec B.V. & Co. KG, Takara Bio Inc., 10x Genomics Inc., Promega Corporation, Esco Lifesciences Group Ltd., NanoCellect Biomedical Inc., InGeneron Inc.

    Get The Full Cell Processing Instruments Market Report:

    https://www.thebusinessresearchcompany.com/report/cell-processing-instruments-global-market-report

    Which Geographic Region Dominates The Cell Processing Instruments Market?

    North America was the largest region in the cell processing instruments market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cell processing instruments market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Request A Customized Cell Processing Instruments Market Report For Competitive Insights:

    https://www.thebusinessresearchcompany.com/customise?id=27242&type=smp

    Browse Through More Reports Similar to the Global Cell Processing Instruments Market 2026, By The Business Research Company

    Cell Free Dna Isolation And Extraction Market Report 2026

    https://www.thebusinessresearchcompany.com/report/cell-free-dna-isolation-and-extraction-global-market-report

    Dna Diagnostics Market Report 2026

    https://www.thebusinessresearchcompany.com/report/dna-diagnostics-global-market-report

    Dna Testing Market Report 2026

    https://www.thebusinessresearchcompany.com/report/dna-testing-global-market-report

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Asia +44 7882 955267 & +91 8897263534

    Europe +44 7882 955267

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Global Cell Processing Instruments Market Expected To Reach $10.1 Billion By 2030 At 7.7% CAGR

    Global Cell Processing Instruments Market Expected To Reach $10.1 Billion By 2030 At 7.7% CAGR

    The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

    What Expansion In Market Value Is Forecasted For The Cell Processing Instruments Market Between 2026 And 2030?

    The cell processing instruments market size has demonstrated significant expansion in recent years. This market is anticipated to increase from $6.95 billion in 2025 to $7.51 billion in 2026, progressing at a compound annual growth rate (CAGR) of 8.1%. Historically, this growth can be ascribed to several factors, including the previous lack of automation in cell processing, a dependence on manual cell counting and separation techniques, an escalation in academic and research activities, a heightened requirement for precise cell analysis, and the emergence of flow cytometry technologies.

    The cell processing instruments market is anticipated to experience substantial expansion in the coming years, with projections indicating it will reach $10.1 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 7.7%. This growth is primarily driven by the development of integrated cell processing platforms, increasing investment in cell therapy and regenerative medicine, the adoption of digital and automated imaging systems, a rise in contract research and manufacturing activities, and advancements in live cell analysis and high-content screening. Furthermore, significant trends for this period include a heightened demand for automated cell processing systems, the growing adoption of flow cytometry and high-content imaging, the expansion of cell therapy and regenerative medicine applications, an emphasis on standardization and regulatory compliance, and the integration of multi-functional cell analysis platforms.

    Access Your Free Sample Report For In-Depth Market Analysis:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=27242&type=smp

    Which Strong Drivers Are Impacting The Cell Processing Instruments Market Growth?

    The increasing investment in biopharmaceutical research is expected to propel the growth of the cell processing instruments market going forward. Biopharmaceutical research refers to the scientific study and development of therapeutic products derived from biological sources or designed to mimic biological molecules for diagnosing, preventing, or treating diseases. The growing demand for innovative therapies to address rising chronic diseases and unmet medical needs is driving this increasing investment, prompting greater research and development efforts for targeted, effective treatments. Cell processing instruments support biopharmaceutical research by enabling efficient, standardized, and scalable cell handling, which accelerates the development and production of advanced cell-based therapies. For instance, in January 2025, according to the BioIndustry Association (BIA), a UK-based trade association, the UK biotech sector experienced substantial growth in 2024, securing £3.5 billion (approximately $ 4.4 billion) in investment, an impressive 94% increase from the previous year. Therefore, the increasing investment in biopharmaceutical research is driving the growth of the cell processing instruments market.

    How Is The Cell Processing Instruments Market Categorized Across Its Segment Groups?

    The cell processing instruments market covered in this report is segmented –

    1) By Type: Cell Counters, Cell Imaging Systems, Flow Cytometers, Cell Separator Systems, Automated Cell Processing Systems, Other Instruments

    2) By Application: Cell Isolation Or Separation, Cell Imaging And Counting, Cell Viability And Proliferation, Other Applications

    3) By End-Use: Pharmaceutical And Biotechnology Companies, Contract Research Organizations (CROs) And Contract Manufacturing Organizations (CMOs), Academic And Research Institutes, Other End-Uses

    Subsegments:

    1) By Cell Counters: Manual Cell Counters, Automated Cell Counters, Digital Cell Counters

    2) By Cell Imaging Systems: Brightfield Imaging Systems, Fluorescence Imaging Systems, High-Content Imaging Systems, Live Cell Imaging Systems

    3) By Flow Cytometers: Analog Flow Cytometers, Digital Flow Cytometers, Benchtop Flow Cytometers, Clinical Flow Cytometers

    4) By Cell Separator Systems: Magnetic-Activated Cell Sorting (MACS) Systems, Fluorescence-Activated Cell Sorting (FACS) Systems, Centrifugal Elutriation Systems

    5) By Automated Cell Processing Systems: Cell Expansion Systems, Cell Washing And Concentration Systems, Cell Harvesting Systems, Integrated Cell Processing Platforms

    6) By Other Instruments: Cell Disruption Systems, Cell Viability Analyzers, Centrifuges For Cell Processing, Cell Freezing And Thawing Systems

    Which Trends Are Contributing To Changes In The Cell Processing Instruments Market?

    Companies within the cell processing instruments market are prioritizing the creation of advanced methods, including multi-channel asynchronous processing, to elevate workflow effectiveness and flexibility in cell therapy development. Multi-channel asynchronous processing provides a system with the capacity to run multiple separate workflows simultaneously on distinct channels, allowing different operations to proceed in parallel without needing to wait for one another. As an illustration, in June 2023, Singleron Biotechnologies GmbH, a German biotechnology company, unveiled two new instruments, Python Junior and Matrix NEO, designed to refine and standardize the single-cell analysis workflow. Python Junior facilitates the dissociation of solid tissues into premium single-cell suspensions using dual independent channels through a blend of mechanical and enzymatic processing, whereas Matrix NEO allows for high-throughput, fully automated single-cell library preparation, covering chip priming, cell partitioning, lysis, and nucleic acid capture across four channels, thereby accommodating various applications and throughput requirements in both research and clinical settings.

    Which Firms Are Influencing Competition In The Cell Processing Instruments Market?

    Major companies operating in the cell processing instruments market are Thermo Fisher Scientific Inc., Danaher Corporation, Merck KGaA, Becton Dickinson and Company, Avantor Inc., Agilent Technologies Inc., Sartorius AG, Revvity Inc., Bio-Rad Laboratories Inc., Eppendorf SE, Tecan Group Ltd., Bio-Techne Corporation, STEMCELL Technologies Inc., Miltenyi Biotec B.V. & Co. KG, Takara Bio Inc., 10x Genomics Inc., Promega Corporation, Esco Lifesciences Group Ltd., NanoCellect Biomedical Inc., InGeneron Inc.

    Get The Full Cell Processing Instruments Market Report:

    https://www.thebusinessresearchcompany.com/report/cell-processing-instruments-global-market-report

    Which Geographic Region Dominates The Cell Processing Instruments Market?

    North America was the largest region in the cell processing instruments market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cell processing instruments market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Request A Customized Cell Processing Instruments Market Report For Competitive Insights:

    https://www.thebusinessresearchcompany.com/customise?id=27242&type=smp

    Browse Through More Reports Similar to the Global Cell Processing Instruments Market 2026, By The Business Research Company

    Cell Free Dna Isolation And Extraction Market Report 2026

    https://www.thebusinessresearchcompany.com/report/cell-free-dna-isolation-and-extraction-global-market-report

    Dna Diagnostics Market Report 2026

    https://www.thebusinessresearchcompany.com/report/dna-diagnostics-global-market-report

    Dna Testing Market Report 2026

    https://www.thebusinessresearchcompany.com/report/dna-testing-global-market-report

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Asia +44 7882 955267 & +91 8897263534

    Europe +44 7882 955267

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Cell Therapy Processing Market Outlook 2026–2030 Exploring New Business Opportunities

    Cell Therapy Processing Market Outlook 2026–2030 Exploring New Business Opportunities

    The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

    What Market Size Growth Is Projected For The Cell Therapy Processing Market During The Forecast Period 2026–2030?

    The cell therapy processing market has witnessed significant growth in recent years. It is projected to expand from $5.18 billion in 2025 to $5.92 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 14.3%. This historical growth can be attributed to a confluence of factors, including the increasing number of clinical trials for cell therapies, the expansion of biopharmaceutical manufacturing capacity, the availability of specialized processing facilities, developing expertise in GMP compliance, and rising investment in advanced therapeutics.

    The cell therapy processing market is poised for substantial expansion over the next few years. Its valuation is expected to reach $9.93 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 13.8%. This anticipated growth during the forecast period can be linked to the increasing commercialization of gene and cell therapies, a rising need for contract manufacturing services, the spread of decentralized manufacturing models, the increasing implementation of digital quality management systems, and a surge in regulatory approvals for cell-based treatments. Significant trends for the forecast period encompass a greater adoption of GMP-compliant processing platforms, an escalating demand for scalable cell therapy manufacturing, the growing incorporation of workflow automation software, further expansion of contract processing services, and an intensified focus on sterility and quality assurance.

    Download the Free Sample Report to Explore Key Market Insights:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=27244&type=smp

    Which Major Factors Are Driving The Expansion Of The Cell Therapy Processing Market?

    The increasing volume of cell therapy research endeavors is anticipated to fuel the expansion of the cell therapy processing market in the future. Cell therapy involves creating therapeutic agents from live cells to address or manage various conditions, such as cancers, autoimmune issues, and genetic ailments. The escalating need for cell-based treatments stems from a rising requirement for scalable and uniform manufacturing systems capable of handling high cell concentrations without sacrificing product integrity. Furthermore, cell therapy processing proves advantageous for cell therapy investigations because it facilitates the standardized creation, quality verification, and large-scale manufacturing of superior cells, thereby guaranteeing dependable and consistent results for both experimental and clinical analyses. As an illustration, data from December 2024, provided by the International Federation of Pharmaceutical Manufacturers and Associations, a Switzerland-based non-profit organization, indicated that six first-in-class cell and gene treatments became available in 2023, representing 50% more than the three released in 2022. Consequently, the growing quantity of cell therapy research efforts is propelling the growth of the cell therapy processing market.

    What Market Segments Are Evaluated Within The Cell Therapy Processing Market?

    The cell therapy processing market covered in this report is segmented –

    1) By Offering Type: Products, Services, Software

    2) By Applications: Cardiovascular Diseases Or Cardiac Regenerative Therapies, Bone Repair, Neurological Disorders, Skeletal Muscle Repair, Cancer, Other Applications

    3) By End-User: Research Institutes, Biopharmaceutical Companies, Contract Research Organizations, Other End-Users

    Subsegments:

    1) By Products: Cell Processing Systems, Cell Separation Devices, Cell Culture Equipment, Cell Preservation Systems, Consumables And Reagents

    2) By Services: Contract Manufacturing Services, Process Development Services, Quality Control And Testing Services, Logistics And Supply Chain Services, Regulatory Compliance And Documentation Services

    3) By Software: Cell Processing Workflow Management Software, Data Analysis And Reporting Software, Quality Management Software, Laboratory Information Management Systems (LIMS), Compliance And Audit Management Software

    How Are Trends Shaping The Direction Of The Cell Therapy Processing Market?

    Leading companies in the cell therapy processing market are prioritizing the creation of advanced solutions, such as integrated bioreactor-centrifuge systems, to optimize manufacturing workflows and enhance the consistency, scalability, and sterility of cell-based therapies. An integrated bioreactor-centrifuge system functions as a unified apparatus that combines cell incubation and centrifugal separation within a single closed unit, enabling continuous, automated cell processing without requiring intermediate transfers. For example, in March 2025, Limula SA, a Switzerland-based company specializing in cell and gene therapy (CGT) manufacturing, unveiled LimONE, an automated, closed-system platform for cell therapy production. This innovative system incorporates hardware, single-use consumables, and protocol-driven software to streamline complex cell processing steps, including incubation, centrifugation, and reagent handling, into one compact unit, thereby enabling consistent, scalable production of therapies such as CAR-T and gene-edited stem cells from initial research to GMP-compliant manufacturing without the necessity for intricate technology transfers.

    Who Are The Top Market Participants Influencing The Cell Therapy Processing Market?

    Major companies operating in the cell therapy processing market are Johnson & Johnson Services Inc., Bristol-Myers Squibb Company, Thermo Fisher Scientific Inc., Novartis AG, Gilead Sciences Inc., Danaher Corporation, Lonza Group AG, Anterogen Co. Ltd., Terumo Corporation, Sartorius AG, Bio-Techne Corporation, STEMCELL Technologies Inc., Miltenyi Biotec GmbH, AGC Biologics S.p.A., MaxCyte Inc., Cellares Corporation, Cellectis S.A., JW Cayman Therapeutics Company Limited, Cell Therapies Pty Ltd., InGeneron Inc., WuXi Advanced Therapies, Catalent Inc.

    Read the full cell therapy processing market report here:

    https://www.thebusinessresearchcompany.com/report/cell-therapy-processing-global-market-report

    Which Region Currently Holds The Largest Share Of The Cell Therapy Processing Market?

    North America was the largest region in the cell therapy processing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cell therapy processing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Request A Tailored Cell Therapy Processing Market Research Report For Competitive Advantage:

    https://www.thebusinessresearchcompany.com/customise?id=27244&type=smp

    Browse Through More Reports Similar to the Global Cell Therapy Processing Market 2026, By The Business Research Company

    Cell Line Development Global Market Report

    https://www.thebusinessresearchcompany.com/report/cell-line-development-global-market-report

    Cell Cultures Global Market Report

    https://www.thebusinessresearchcompany.com/report/cell-cultures-global-market-report

    Cell Expansion Global Market Report

    https://www.thebusinessresearchcompany.com/report/cell-expansion-global-market-report

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Asia +44 7882 955267 & +91 8897263534

    Europe +44 7882 955267

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Cell Processing Technologies Market Outlook 2026–2030 with Major Growth Drivers and Emerging Industry Trends

    Cell Processing Technologies Market Outlook 2026–2030 with Major Growth Drivers and Emerging Industry Trends

    The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

    How Much Is The Cell Processing Technologies Market Expected To Grow In Terms Of Market Value Between 2026 And 2030?

    The cell processing technologies market has experienced rapid expansion in recent years. It is forecast to grow from $4.89 billion in 2025 to $5.56 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 13.7%. The market’s historical growth can be attributed to the proliferation of cell-based research activities, the increased application of cell culture techniques, advancements in regenerative medicine research, the accessibility of sophisticated laboratory equipment, and a rise in academic and clinical research funding.

    The cell processing technologies market is anticipated to experience substantial growth over the next few years. It is forecast to expand to $9.24 billion by 2030, achieving a compound annual growth rate (CAGR) of 13.5%. This growth during the projected period can be attributed to the increasing commercialization of cell therapies, a rising demand for scalable cell manufacturing, the expanding applications of personalized medicine, growing investments in bioprocess automation, and a heightened regulatory focus on cell processing standards. Significant trends in the forecast period encompass a greater adoption of automated cell processing systems, an increasing need for closed-system cell handling technologies, the expanding integration of digital process monitoring, a broader utilization of single-use consumables, and an enhanced emphasis on cell viability and quality control.

    Download the Free Sample Report to Explore Key Market Insights:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=27243&type=smp

    What Drivers Are Influencing The Cell Processing Technologies Market?

    The increasing integration of personalized medicine is projected to propel the expansion of the cell processing technologies market going forward. Personalized medicine is a healthcare strategy that involves adapting treatments to individual patients based on their genetic, environmental, and lifestyle attributes to optimize results and enhance care. The demand for personalized medicine is on the rise due to breakthroughs in genomic technologies, which facilitate the precise identification of genetic variations and enable customized treatments for individuals. Cell processing technologies augment personalized medicine by allowing for the exact manipulation and preparation of patient-specific cells, rendering them crucial for tailored therapies. These technologies improve treatment outcomes by guaranteeing high-quality, viable cells, thus furthering the development of targeted and effective medical interventions. For instance, in February 2024, as per the Personalized Medicine Coalition (PMC), a US-based nonprofit organization, the U.S. Food and Drug Administration (FDA) sanctioned 26 new personalized medicines in 2023, representing an increase from 12 approved in 2022. Therefore, the growing adoption of personalized therapies is driving the growth of the cell processing technologies market.

    What Major Segment Divisions Exist Within The Cell Processing Technologies Market?

    The cell processing technologies market covered in this report is segmented –

    1) By Product Type: Equipment, Consumables, Software

    2) By Application: Oncology, Cardiovascular Disease, Bone Repair, Neurological Disorders, Skeletal Muscle Repair, Immune Diseases, Other Applications

    3) By End-User: Pharmaceutical and Biotechnology Companies, Academic Research Institutes, Other End-Users

    Subsegments:

    1) By Equipment: Bioreactors, Centrifuges, Cell Counters, Incubators, Cryopreservation Systems, Cell Washers, Cell Sorters, Microscopes

    2) By Consumables: Cell Culture Media, Reagents, Pipettes and Tips, Flasks and Plates, Cryovials, Filters, Disposable Bags, Tubes and Containers

    3) By Software: Process Monitoring Software, Data Management Software, Automation Control Software, Quality Control Software, Imaging and Analysis Software, Inventory Management Software

    What Trends Are Advancing Progress In The Cell Processing Technologies Market?

    Major companies operating in the cell processing technologies market are focusing on developing technologically advanced solutions, such as automated cell therapy manufacturing platforms, to enhance scalability, improve process efficiency, cell quality, and reduce production costs. An automated cell therapy manufacturing platform refers to a fully integrated system that uses advanced robotics, sensors, and software to perform the entire process of producing cell-based therapies with minimal manual intervention. For instance, in March 2025, Limula SA, a Switzerland-based life sciences company, launched LimONE, a fully automated cell therapy manufacturing platform designed to transform the production of advanced therapies such as CAR-T and gene-edited stem cells. It streamlines complex manufacturing processes by integrating a bioreactor and centrifuge into a single, closed device that uses one consumable throughout all development stages. LimONE enables hospitals, biotech firms, and manufacturers to accelerate the transition from research to clinical trials and commercial production, making life-saving, personalized cell and gene therapies more accessible to patients.

    Which Companies Are Leading Innovation In The Cell Processing Technologies Market?

    Major companies operating in the cell processing technologies market are Thermo Fisher Scientific Inc., Danaher Corporation, Cryo-Cell International Inc., Merck KGaA, Becton Dickinson and Company, Lonza Group AG, Terumo Corporation, WuXi AppTec Co. Ltd., Charles River Laboratories International Inc., Bio-Rad Laboratories Inc., PHC Holdings Corporation, Bio-Techne Corporation, StemCell Technologies Inc., Shibuya Corporation, Repligen Corporation, Beckman Coulter Inc., ThermoGenesis Holdings Inc., Ori Biotech Ltd., Biospherix Ltd., Miltenyi Biotec B.V. & Co. KG, Sartorius Stedim Biotech, Cytiva

    Read the full cell processing technologies market report here:

    https://www.thebusinessresearchcompany.com/report/cell-processing-technologies-global-market-report

    Which Regions Are Expected To Experience Rapid Expansion In The Cell Processing Technologies Market?

    North America was the largest region in the cell processing technologies market in 2025. The regions covered in the cell processing technologies market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Request A Tailored Cell Processing Technologies Market Research Report For Competitive Advantage:

    https://www.thebusinessresearchcompany.com/customise?id=27243&type=smp

    Browse Through More Reports Similar to the Global Cell Processing Technologies Market 2026, By The Business Research Company

    Peptide Therapeutics Global Market Report

    https://www.thebusinessresearchcompany.com/report/peptide-therapeutics-global-market-report

    Peptide Synthesis Global Market Report

    https://www.thebusinessresearchcompany.com/report/peptide-synthesis-global-market-report

    Glucagon Like Peptide 1 Global Market Report

    https://www.thebusinessresearchcompany.com/report/glucagon-like-peptide-1-global-market-report

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Asia +44 7882 955267 & +91 8897263534

    Europe +44 7882 955267

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Cell Therapy Processing Market Outlook 2026–2030 Exploring New Business Opportunities

    Cell Therapy Processing Market Outlook 2026–2030 Exploring New Business Opportunities

    The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

    What Market Size Growth Is Projected For The Cell Therapy Processing Market During The Forecast Period 2026–2030?

    The cell therapy processing market has witnessed significant growth in recent years. It is projected to expand from $5.18 billion in 2025 to $5.92 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 14.3%. This historical growth can be attributed to a confluence of factors, including the increasing number of clinical trials for cell therapies, the expansion of biopharmaceutical manufacturing capacity, the availability of specialized processing facilities, developing expertise in GMP compliance, and rising investment in advanced therapeutics.

    The cell therapy processing market is poised for substantial expansion over the next few years. Its valuation is expected to reach $9.93 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 13.8%. This anticipated growth during the forecast period can be linked to the increasing commercialization of gene and cell therapies, a rising need for contract manufacturing services, the spread of decentralized manufacturing models, the increasing implementation of digital quality management systems, and a surge in regulatory approvals for cell-based treatments. Significant trends for the forecast period encompass a greater adoption of GMP-compliant processing platforms, an escalating demand for scalable cell therapy manufacturing, the growing incorporation of workflow automation software, further expansion of contract processing services, and an intensified focus on sterility and quality assurance.

    Download the Free Sample Report to Explore Key Market Insights:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=27244&type=smp

    Which Major Factors Are Driving The Expansion Of The Cell Therapy Processing Market?

    The increasing volume of cell therapy research endeavors is anticipated to fuel the expansion of the cell therapy processing market in the future. Cell therapy involves creating therapeutic agents from live cells to address or manage various conditions, such as cancers, autoimmune issues, and genetic ailments. The escalating need for cell-based treatments stems from a rising requirement for scalable and uniform manufacturing systems capable of handling high cell concentrations without sacrificing product integrity. Furthermore, cell therapy processing proves advantageous for cell therapy investigations because it facilitates the standardized creation, quality verification, and large-scale manufacturing of superior cells, thereby guaranteeing dependable and consistent results for both experimental and clinical analyses. As an illustration, data from December 2024, provided by the International Federation of Pharmaceutical Manufacturers and Associations, a Switzerland-based non-profit organization, indicated that six first-in-class cell and gene treatments became available in 2023, representing 50% more than the three released in 2022. Consequently, the growing quantity of cell therapy research efforts is propelling the growth of the cell therapy processing market.

    What Market Segments Are Evaluated Within The Cell Therapy Processing Market?

    The cell therapy processing market covered in this report is segmented –

    1) By Offering Type: Products, Services, Software

    2) By Applications: Cardiovascular Diseases Or Cardiac Regenerative Therapies, Bone Repair, Neurological Disorders, Skeletal Muscle Repair, Cancer, Other Applications

    3) By End-User: Research Institutes, Biopharmaceutical Companies, Contract Research Organizations, Other End-Users

    Subsegments:

    1) By Products: Cell Processing Systems, Cell Separation Devices, Cell Culture Equipment, Cell Preservation Systems, Consumables And Reagents

    2) By Services: Contract Manufacturing Services, Process Development Services, Quality Control And Testing Services, Logistics And Supply Chain Services, Regulatory Compliance And Documentation Services

    3) By Software: Cell Processing Workflow Management Software, Data Analysis And Reporting Software, Quality Management Software, Laboratory Information Management Systems (LIMS), Compliance And Audit Management Software

    How Are Trends Shaping The Direction Of The Cell Therapy Processing Market?

    Leading companies in the cell therapy processing market are prioritizing the creation of advanced solutions, such as integrated bioreactor-centrifuge systems, to optimize manufacturing workflows and enhance the consistency, scalability, and sterility of cell-based therapies. An integrated bioreactor-centrifuge system functions as a unified apparatus that combines cell incubation and centrifugal separation within a single closed unit, enabling continuous, automated cell processing without requiring intermediate transfers. For example, in March 2025, Limula SA, a Switzerland-based company specializing in cell and gene therapy (CGT) manufacturing, unveiled LimONE, an automated, closed-system platform for cell therapy production. This innovative system incorporates hardware, single-use consumables, and protocol-driven software to streamline complex cell processing steps, including incubation, centrifugation, and reagent handling, into one compact unit, thereby enabling consistent, scalable production of therapies such as CAR-T and gene-edited stem cells from initial research to GMP-compliant manufacturing without the necessity for intricate technology transfers.

    Who Are The Top Market Participants Influencing The Cell Therapy Processing Market?

    Major companies operating in the cell therapy processing market are Johnson & Johnson Services Inc., Bristol-Myers Squibb Company, Thermo Fisher Scientific Inc., Novartis AG, Gilead Sciences Inc., Danaher Corporation, Lonza Group AG, Anterogen Co. Ltd., Terumo Corporation, Sartorius AG, Bio-Techne Corporation, STEMCELL Technologies Inc., Miltenyi Biotec GmbH, AGC Biologics S.p.A., MaxCyte Inc., Cellares Corporation, Cellectis S.A., JW Cayman Therapeutics Company Limited, Cell Therapies Pty Ltd., InGeneron Inc., WuXi Advanced Therapies, Catalent Inc.

    Read the full cell therapy processing market report here:

    https://www.thebusinessresearchcompany.com/report/cell-therapy-processing-global-market-report

    Which Region Currently Holds The Largest Share Of The Cell Therapy Processing Market?

    North America was the largest region in the cell therapy processing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cell therapy processing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Request A Tailored Cell Therapy Processing Market Research Report For Competitive Advantage:

    https://www.thebusinessresearchcompany.com/customise?id=27244&type=smp

    Browse Through More Reports Similar to the Global Cell Therapy Processing Market 2026, By The Business Research Company

    Cell Line Development Global Market Report

    https://www.thebusinessresearchcompany.com/report/cell-line-development-global-market-report

    Cell Cultures Global Market Report

    https://www.thebusinessresearchcompany.com/report/cell-cultures-global-market-report

    Cell Expansion Global Market Report

    https://www.thebusinessresearchcompany.com/report/cell-expansion-global-market-report

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Asia +44 7882 955267 & +91 8897263534

    Europe +44 7882 955267

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Cell Processing Technologies Market Outlook 2026–2030 with Major Growth Drivers and Emerging Industry Trends

    Cell Processing Technologies Market Outlook 2026–2030 with Major Growth Drivers and Emerging Industry Trends

    The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

    How Much Is The Cell Processing Technologies Market Expected To Grow In Terms Of Market Value Between 2026 And 2030?

    The cell processing technologies market has experienced rapid expansion in recent years. It is forecast to grow from $4.89 billion in 2025 to $5.56 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 13.7%. The market’s historical growth can be attributed to the proliferation of cell-based research activities, the increased application of cell culture techniques, advancements in regenerative medicine research, the accessibility of sophisticated laboratory equipment, and a rise in academic and clinical research funding.

    The cell processing technologies market is anticipated to experience substantial growth over the next few years. It is forecast to expand to $9.24 billion by 2030, achieving a compound annual growth rate (CAGR) of 13.5%. This growth during the projected period can be attributed to the increasing commercialization of cell therapies, a rising demand for scalable cell manufacturing, the expanding applications of personalized medicine, growing investments in bioprocess automation, and a heightened regulatory focus on cell processing standards. Significant trends in the forecast period encompass a greater adoption of automated cell processing systems, an increasing need for closed-system cell handling technologies, the expanding integration of digital process monitoring, a broader utilization of single-use consumables, and an enhanced emphasis on cell viability and quality control.

    Download the Free Sample Report to Explore Key Market Insights:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=27243&type=smp

    What Drivers Are Influencing The Cell Processing Technologies Market?

    The increasing integration of personalized medicine is projected to propel the expansion of the cell processing technologies market going forward. Personalized medicine is a healthcare strategy that involves adapting treatments to individual patients based on their genetic, environmental, and lifestyle attributes to optimize results and enhance care. The demand for personalized medicine is on the rise due to breakthroughs in genomic technologies, which facilitate the precise identification of genetic variations and enable customized treatments for individuals. Cell processing technologies augment personalized medicine by allowing for the exact manipulation and preparation of patient-specific cells, rendering them crucial for tailored therapies. These technologies improve treatment outcomes by guaranteeing high-quality, viable cells, thus furthering the development of targeted and effective medical interventions. For instance, in February 2024, as per the Personalized Medicine Coalition (PMC), a US-based nonprofit organization, the U.S. Food and Drug Administration (FDA) sanctioned 26 new personalized medicines in 2023, representing an increase from 12 approved in 2022. Therefore, the growing adoption of personalized therapies is driving the growth of the cell processing technologies market.

    What Major Segment Divisions Exist Within The Cell Processing Technologies Market?

    The cell processing technologies market covered in this report is segmented –

    1) By Product Type: Equipment, Consumables, Software

    2) By Application: Oncology, Cardiovascular Disease, Bone Repair, Neurological Disorders, Skeletal Muscle Repair, Immune Diseases, Other Applications

    3) By End-User: Pharmaceutical and Biotechnology Companies, Academic Research Institutes, Other End-Users

    Subsegments:

    1) By Equipment: Bioreactors, Centrifuges, Cell Counters, Incubators, Cryopreservation Systems, Cell Washers, Cell Sorters, Microscopes

    2) By Consumables: Cell Culture Media, Reagents, Pipettes and Tips, Flasks and Plates, Cryovials, Filters, Disposable Bags, Tubes and Containers

    3) By Software: Process Monitoring Software, Data Management Software, Automation Control Software, Quality Control Software, Imaging and Analysis Software, Inventory Management Software

    What Trends Are Advancing Progress In The Cell Processing Technologies Market?

    Major companies operating in the cell processing technologies market are focusing on developing technologically advanced solutions, such as automated cell therapy manufacturing platforms, to enhance scalability, improve process efficiency, cell quality, and reduce production costs. An automated cell therapy manufacturing platform refers to a fully integrated system that uses advanced robotics, sensors, and software to perform the entire process of producing cell-based therapies with minimal manual intervention. For instance, in March 2025, Limula SA, a Switzerland-based life sciences company, launched LimONE, a fully automated cell therapy manufacturing platform designed to transform the production of advanced therapies such as CAR-T and gene-edited stem cells. It streamlines complex manufacturing processes by integrating a bioreactor and centrifuge into a single, closed device that uses one consumable throughout all development stages. LimONE enables hospitals, biotech firms, and manufacturers to accelerate the transition from research to clinical trials and commercial production, making life-saving, personalized cell and gene therapies more accessible to patients.

    Which Companies Are Leading Innovation In The Cell Processing Technologies Market?

    Major companies operating in the cell processing technologies market are Thermo Fisher Scientific Inc., Danaher Corporation, Cryo-Cell International Inc., Merck KGaA, Becton Dickinson and Company, Lonza Group AG, Terumo Corporation, WuXi AppTec Co. Ltd., Charles River Laboratories International Inc., Bio-Rad Laboratories Inc., PHC Holdings Corporation, Bio-Techne Corporation, StemCell Technologies Inc., Shibuya Corporation, Repligen Corporation, Beckman Coulter Inc., ThermoGenesis Holdings Inc., Ori Biotech Ltd., Biospherix Ltd., Miltenyi Biotec B.V. & Co. KG, Sartorius Stedim Biotech, Cytiva

    Read the full cell processing technologies market report here:

    https://www.thebusinessresearchcompany.com/report/cell-processing-technologies-global-market-report

    Which Regions Are Expected To Experience Rapid Expansion In The Cell Processing Technologies Market?

    North America was the largest region in the cell processing technologies market in 2025. The regions covered in the cell processing technologies market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Request A Tailored Cell Processing Technologies Market Research Report For Competitive Advantage:

    https://www.thebusinessresearchcompany.com/customise?id=27243&type=smp

    Browse Through More Reports Similar to the Global Cell Processing Technologies Market 2026, By The Business Research Company

    Peptide Therapeutics Global Market Report

    https://www.thebusinessresearchcompany.com/report/peptide-therapeutics-global-market-report

    Peptide Synthesis Global Market Report

    https://www.thebusinessresearchcompany.com/report/peptide-synthesis-global-market-report

    Glucagon Like Peptide 1 Global Market Report

    https://www.thebusinessresearchcompany.com/report/glucagon-like-peptide-1-global-market-report

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Asia +44 7882 955267 & +91 8897263534

    Europe +44 7882 955267

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Cell Therapy Processing Market Outlook 2026–2030 Exploring New Business Opportunities

    Cell Therapy Processing Market Outlook 2026–2030 Exploring New Business Opportunities

    The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

    What Market Size Growth Is Projected For The Cell Therapy Processing Market During The Forecast Period 2026–2030?

    The cell therapy processing market has witnessed significant growth in recent years. It is projected to expand from $5.18 billion in 2025 to $5.92 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 14.3%. This historical growth can be attributed to a confluence of factors, including the increasing number of clinical trials for cell therapies, the expansion of biopharmaceutical manufacturing capacity, the availability of specialized processing facilities, developing expertise in GMP compliance, and rising investment in advanced therapeutics.

    The cell therapy processing market is poised for substantial expansion over the next few years. Its valuation is expected to reach $9.93 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 13.8%. This anticipated growth during the forecast period can be linked to the increasing commercialization of gene and cell therapies, a rising need for contract manufacturing services, the spread of decentralized manufacturing models, the increasing implementation of digital quality management systems, and a surge in regulatory approvals for cell-based treatments. Significant trends for the forecast period encompass a greater adoption of GMP-compliant processing platforms, an escalating demand for scalable cell therapy manufacturing, the growing incorporation of workflow automation software, further expansion of contract processing services, and an intensified focus on sterility and quality assurance.

    Download the Free Sample Report to Explore Key Market Insights:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=27244&type=smp

    Which Major Factors Are Driving The Expansion Of The Cell Therapy Processing Market?

    The increasing volume of cell therapy research endeavors is anticipated to fuel the expansion of the cell therapy processing market in the future. Cell therapy involves creating therapeutic agents from live cells to address or manage various conditions, such as cancers, autoimmune issues, and genetic ailments. The escalating need for cell-based treatments stems from a rising requirement for scalable and uniform manufacturing systems capable of handling high cell concentrations without sacrificing product integrity. Furthermore, cell therapy processing proves advantageous for cell therapy investigations because it facilitates the standardized creation, quality verification, and large-scale manufacturing of superior cells, thereby guaranteeing dependable and consistent results for both experimental and clinical analyses. As an illustration, data from December 2024, provided by the International Federation of Pharmaceutical Manufacturers and Associations, a Switzerland-based non-profit organization, indicated that six first-in-class cell and gene treatments became available in 2023, representing 50% more than the three released in 2022. Consequently, the growing quantity of cell therapy research efforts is propelling the growth of the cell therapy processing market.

    What Market Segments Are Evaluated Within The Cell Therapy Processing Market?

    The cell therapy processing market covered in this report is segmented –

    1) By Offering Type: Products, Services, Software

    2) By Applications: Cardiovascular Diseases Or Cardiac Regenerative Therapies, Bone Repair, Neurological Disorders, Skeletal Muscle Repair, Cancer, Other Applications

    3) By End-User: Research Institutes, Biopharmaceutical Companies, Contract Research Organizations, Other End-Users

    Subsegments:

    1) By Products: Cell Processing Systems, Cell Separation Devices, Cell Culture Equipment, Cell Preservation Systems, Consumables And Reagents

    2) By Services: Contract Manufacturing Services, Process Development Services, Quality Control And Testing Services, Logistics And Supply Chain Services, Regulatory Compliance And Documentation Services

    3) By Software: Cell Processing Workflow Management Software, Data Analysis And Reporting Software, Quality Management Software, Laboratory Information Management Systems (LIMS), Compliance And Audit Management Software

    How Are Trends Shaping The Direction Of The Cell Therapy Processing Market?

    Leading companies in the cell therapy processing market are prioritizing the creation of advanced solutions, such as integrated bioreactor-centrifuge systems, to optimize manufacturing workflows and enhance the consistency, scalability, and sterility of cell-based therapies. An integrated bioreactor-centrifuge system functions as a unified apparatus that combines cell incubation and centrifugal separation within a single closed unit, enabling continuous, automated cell processing without requiring intermediate transfers. For example, in March 2025, Limula SA, a Switzerland-based company specializing in cell and gene therapy (CGT) manufacturing, unveiled LimONE, an automated, closed-system platform for cell therapy production. This innovative system incorporates hardware, single-use consumables, and protocol-driven software to streamline complex cell processing steps, including incubation, centrifugation, and reagent handling, into one compact unit, thereby enabling consistent, scalable production of therapies such as CAR-T and gene-edited stem cells from initial research to GMP-compliant manufacturing without the necessity for intricate technology transfers.

    Who Are The Top Market Participants Influencing The Cell Therapy Processing Market?

    Major companies operating in the cell therapy processing market are Johnson & Johnson Services Inc., Bristol-Myers Squibb Company, Thermo Fisher Scientific Inc., Novartis AG, Gilead Sciences Inc., Danaher Corporation, Lonza Group AG, Anterogen Co. Ltd., Terumo Corporation, Sartorius AG, Bio-Techne Corporation, STEMCELL Technologies Inc., Miltenyi Biotec GmbH, AGC Biologics S.p.A., MaxCyte Inc., Cellares Corporation, Cellectis S.A., JW Cayman Therapeutics Company Limited, Cell Therapies Pty Ltd., InGeneron Inc., WuXi Advanced Therapies, Catalent Inc.

    Read the full cell therapy processing market report here:

    https://www.thebusinessresearchcompany.com/report/cell-therapy-processing-global-market-report

    Which Region Currently Holds The Largest Share Of The Cell Therapy Processing Market?

    North America was the largest region in the cell therapy processing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cell therapy processing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Request A Tailored Cell Therapy Processing Market Research Report For Competitive Advantage:

    https://www.thebusinessresearchcompany.com/customise?id=27244&type=smp

    Browse Through More Reports Similar to the Global Cell Therapy Processing Market 2026, By The Business Research Company

    Cell Line Development Global Market Report

    https://www.thebusinessresearchcompany.com/report/cell-line-development-global-market-report

    Cell Cultures Global Market Report

    https://www.thebusinessresearchcompany.com/report/cell-cultures-global-market-report

    Cell Expansion Global Market Report

    https://www.thebusinessresearchcompany.com/report/cell-expansion-global-market-report

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Asia +44 7882 955267 & +91 8897263534

    Europe +44 7882 955267

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Cell Processing Technologies Market Outlook 2026–2030 with Major Growth Drivers and Emerging Industry Trends

    Cell Processing Technologies Market Outlook 2026–2030 with Major Growth Drivers and Emerging Industry Trends

    The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

    How Much Is The Cell Processing Technologies Market Expected To Grow In Terms Of Market Value Between 2026 And 2030?

    The cell processing technologies market has experienced rapid expansion in recent years. It is forecast to grow from $4.89 billion in 2025 to $5.56 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 13.7%. The market’s historical growth can be attributed to the proliferation of cell-based research activities, the increased application of cell culture techniques, advancements in regenerative medicine research, the accessibility of sophisticated laboratory equipment, and a rise in academic and clinical research funding.

    The cell processing technologies market is anticipated to experience substantial growth over the next few years. It is forecast to expand to $9.24 billion by 2030, achieving a compound annual growth rate (CAGR) of 13.5%. This growth during the projected period can be attributed to the increasing commercialization of cell therapies, a rising demand for scalable cell manufacturing, the expanding applications of personalized medicine, growing investments in bioprocess automation, and a heightened regulatory focus on cell processing standards. Significant trends in the forecast period encompass a greater adoption of automated cell processing systems, an increasing need for closed-system cell handling technologies, the expanding integration of digital process monitoring, a broader utilization of single-use consumables, and an enhanced emphasis on cell viability and quality control.

    Download the Free Sample Report to Explore Key Market Insights:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=27243&type=smp

    What Drivers Are Influencing The Cell Processing Technologies Market?

    The increasing integration of personalized medicine is projected to propel the expansion of the cell processing technologies market going forward. Personalized medicine is a healthcare strategy that involves adapting treatments to individual patients based on their genetic, environmental, and lifestyle attributes to optimize results and enhance care. The demand for personalized medicine is on the rise due to breakthroughs in genomic technologies, which facilitate the precise identification of genetic variations and enable customized treatments for individuals. Cell processing technologies augment personalized medicine by allowing for the exact manipulation and preparation of patient-specific cells, rendering them crucial for tailored therapies. These technologies improve treatment outcomes by guaranteeing high-quality, viable cells, thus furthering the development of targeted and effective medical interventions. For instance, in February 2024, as per the Personalized Medicine Coalition (PMC), a US-based nonprofit organization, the U.S. Food and Drug Administration (FDA) sanctioned 26 new personalized medicines in 2023, representing an increase from 12 approved in 2022. Therefore, the growing adoption of personalized therapies is driving the growth of the cell processing technologies market.

    What Major Segment Divisions Exist Within The Cell Processing Technologies Market?

    The cell processing technologies market covered in this report is segmented –

    1) By Product Type: Equipment, Consumables, Software

    2) By Application: Oncology, Cardiovascular Disease, Bone Repair, Neurological Disorders, Skeletal Muscle Repair, Immune Diseases, Other Applications

    3) By End-User: Pharmaceutical and Biotechnology Companies, Academic Research Institutes, Other End-Users

    Subsegments:

    1) By Equipment: Bioreactors, Centrifuges, Cell Counters, Incubators, Cryopreservation Systems, Cell Washers, Cell Sorters, Microscopes

    2) By Consumables: Cell Culture Media, Reagents, Pipettes and Tips, Flasks and Plates, Cryovials, Filters, Disposable Bags, Tubes and Containers

    3) By Software: Process Monitoring Software, Data Management Software, Automation Control Software, Quality Control Software, Imaging and Analysis Software, Inventory Management Software

    What Trends Are Advancing Progress In The Cell Processing Technologies Market?

    Major companies operating in the cell processing technologies market are focusing on developing technologically advanced solutions, such as automated cell therapy manufacturing platforms, to enhance scalability, improve process efficiency, cell quality, and reduce production costs. An automated cell therapy manufacturing platform refers to a fully integrated system that uses advanced robotics, sensors, and software to perform the entire process of producing cell-based therapies with minimal manual intervention. For instance, in March 2025, Limula SA, a Switzerland-based life sciences company, launched LimONE, a fully automated cell therapy manufacturing platform designed to transform the production of advanced therapies such as CAR-T and gene-edited stem cells. It streamlines complex manufacturing processes by integrating a bioreactor and centrifuge into a single, closed device that uses one consumable throughout all development stages. LimONE enables hospitals, biotech firms, and manufacturers to accelerate the transition from research to clinical trials and commercial production, making life-saving, personalized cell and gene therapies more accessible to patients.

    Which Companies Are Leading Innovation In The Cell Processing Technologies Market?

    Major companies operating in the cell processing technologies market are Thermo Fisher Scientific Inc., Danaher Corporation, Cryo-Cell International Inc., Merck KGaA, Becton Dickinson and Company, Lonza Group AG, Terumo Corporation, WuXi AppTec Co. Ltd., Charles River Laboratories International Inc., Bio-Rad Laboratories Inc., PHC Holdings Corporation, Bio-Techne Corporation, StemCell Technologies Inc., Shibuya Corporation, Repligen Corporation, Beckman Coulter Inc., ThermoGenesis Holdings Inc., Ori Biotech Ltd., Biospherix Ltd., Miltenyi Biotec B.V. & Co. KG, Sartorius Stedim Biotech, Cytiva

    Read the full cell processing technologies market report here:

    https://www.thebusinessresearchcompany.com/report/cell-processing-technologies-global-market-report

    Which Regions Are Expected To Experience Rapid Expansion In The Cell Processing Technologies Market?

    North America was the largest region in the cell processing technologies market in 2025. The regions covered in the cell processing technologies market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Request A Tailored Cell Processing Technologies Market Research Report For Competitive Advantage:

    https://www.thebusinessresearchcompany.com/customise?id=27243&type=smp

    Browse Through More Reports Similar to the Global Cell Processing Technologies Market 2026, By The Business Research Company

    Peptide Therapeutics Global Market Report

    https://www.thebusinessresearchcompany.com/report/peptide-therapeutics-global-market-report

    Peptide Synthesis Global Market Report

    https://www.thebusinessresearchcompany.com/report/peptide-synthesis-global-market-report

    Glucagon Like Peptide 1 Global Market Report

    https://www.thebusinessresearchcompany.com/report/glucagon-like-peptide-1-global-market-report

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Asia +44 7882 955267 & +91 8897263534

    Europe +44 7882 955267

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model